‡a
Author's Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma
‡a
Author's Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma
‡a
efficacyandsafetyoftreatmentwithbiologicalsbenralizumabdupilumabmepolizumabomalizumabandreslizumabforsevereeosinophilicasthma
‡A
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma
‡9
1
‡a
efficacyandsafetyoftreatmentwithbiologicalsbenralizumabdupilumabandomalizumabforsevereallergicasthma
‡A
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma
‡9
1
‡a
efficacyandsafetyoftreatmentwithdupilumabforsevereasthmaasystematicreviewoftheeaaciguidelinesrecommendationsontheuseofbiologicalsinsevereasthma
‡A
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma
‡9
1